logo
#

Latest news with #AtulVerma

‘What I got is far higher than parade, I stood by values, integrity of police dept'
‘What I got is far higher than parade, I stood by values, integrity of police dept'

Indian Express

time3 days ago

  • Politics
  • Indian Express

‘What I got is far higher than parade, I stood by values, integrity of police dept'

On the last day of his service, outgoing DGP Atul Verma termed his affidavit submitted in the Himachal Pradesh High Court in the abetment to suicide case of Himachal Pradesh Power Corporation Ltd (HPPCL) chief engineer Vimal Negi based on facts. He added that he had prepared it with honesty and to maintain the integrity of Himachal Pradesh police. Talking to The Indian Express, the DGP said that it was not the first time that his affidavit was accepted by the court of law on the basis of merits. 'Earlier in June-July last year, one of my affidavit filed in the HC in the matter of Palampur-based businessman Nishant Sharma, who alleged threat to his life by the serving and retired police officials, was also accepted by the former Chief Justice,' he said. The 1991 batch IPS officer, however, declined to reply if he was under pressure to make changes in the affidavit filed in the chief engineer's death. When asked about SP Shimla Sanjeev Gandhi's allegations that his office staff was involved in drug peddling, Verma said, 'Who stopped him to act against anyone? Anybody can investigate any allegation. The guilty should be punished.' On being pointed out that he was not given an official farewell parade, the outgoing DGP said, ' What I received today is far higher than the parade. I stood by the values, integrity and honesty of an institution (police department).' Elaborating on the affidavit, Verma added that it was prepared in the presence of three senior police officers, including two of ADGP rank. 'If somebody has a problem with it then he/she can challenge it in the court of law,' he said. He, however, chose not to comment when asked why he was being sent on leave and why his recommendation to suspend the Shimla SP was not accepted. 'You should ask these question to the state government,' he said. A senior police officer said, 'Although Verma was given a customary farewell in the police headquarters, the farewell parade and the official farewell party was not organised due to certain reasons. All senior police officers posted in the headquarters were present at the moment when DGP Verma left the police headquarters.' Verma along with Additional Chief Secretary (ACS) Onkar Sharma and Shimla SP Sanjeev Gandhi were asked to proceed on leave with immediate effect reportedly due to the fallout of their contradictory replies filed in the HC pertaining to the HPPCL chief engineer death case. While Verma and Sharma proceeded on casual leave, Gandhi went on medical leave. Meanwhile, state government Saturday ordered DGP (Vigilance and ACB) Ashok Tiwari, 1994 batch IPS officer, who is already looking after the additional charge of DGP Himachal Pradesh, will also take charge of DGP (Head of Police Force) with immediate effect. ADGP (Law & Order) Abhishek Trivedi, a 1996 batch IPS officer, was given the additional charge of ADGP (Prisons department) on Saturday. Hours after outgoing DGP Atul Verma issued recommendation of DGP Disc Award-2024 for 172 police personnel, officiated DGP Ashok Tewari withdraw the order with immediate effect on Saturday. The communication issued from the office of DGP Ashok Tewari states, 'The order issued regarding awarding of DGP Disc to the officer/officials is hereby withdrawn with immediate effect.'

Disc Award conferred by outgoing Himachal DGP withdrawn
Disc Award conferred by outgoing Himachal DGP withdrawn

News18

time3 days ago

  • Politics
  • News18

Disc Award conferred by outgoing Himachal DGP withdrawn

Last Updated: Shimla, May 31 (PTI) The order to confer the Director General of Police (DGP) Disc Award on 172 police officers in recognition of their outstanding work in 2024 was withdrawn on Saturday. This came after DGP Atul Verma, who issued this order, retired on Saturday. Verma, a 1991-batch Indian Police Service (IPS) officer, served as the DGP since 2024. The order to confer the Disc Award was withdrawn and the post in this regard shared on Facebook was also removed. Verma, who proceeded on leave earlier on Wednesday along with Additional Chief Secretary (Home) Onkar Sharma and Shimla Superintendent of Police (SP) Sanjeev Kumar Gandhi, returned on Friday. The three were on Tuesday asked to proceed on leave after a meeting held here by Himachal Pradesh Chief Minister Sukhvinder Singh Sukhu with senior officials. The discussion during the meeting focused on the issue related to the high court's order to transfer Himachal Pradesh Power Corporation Limited (HPPCL) chief engineer Vimal Negi's death case to the CBI. This came after the DGP submitted a status report to the high court, questioning the impartiality of the SIT probe. Sukhu had expressed his displeasure over the ongoing tussle between Verma and Gandhi and also with the additional chief secretary for bypassing the advocate general's office while submitting his fact-finding report. First Published: June 01, 2025, 00:45 IST

Himachal DGP Verma retires sans official farewell
Himachal DGP Verma retires sans official farewell

Hindustan Times

time3 days ago

  • Politics
  • Hindustan Times

Himachal DGP Verma retires sans official farewell

Himachal Pradesh director general of police (DGP) Atul Verma got no official farewell on his retirement on Saturday. Also, an order issued by Verma awarding DGP Disc to 172 police personnel was withdrawn hours later. Chief minister Sukhvinder Singh Sukhu had on May 27 directed Verma, additional chief secretary (ACS) Onkar Chand Sharma and Shimla superintendent of police (SP) Sanjeev Gandhi to proceed on leave. The development came amid a slugfest within the state police force triggered by the probe into the death of Himachal Pradesh Power Corporation Limited (HPPCL) chief engineer-cum-general manager Vimal Negi, who died under suspicious circumstances in March this year. Meanwhile, the government has officially handed over the additional charge of the DGP to IPS Ashok Tiwari. Chief secretary Prabodh Saxena issued related orders on Saturday which mentioned that Tiwari would look after the work of DGP till further orders. The state government had formed a panel of three senior IPS officers — Shyam Bhagat Negi, Ashok Tiwari and Rakesh Agarwal — who are being seen frontrunners for post of DGP. Meanwhile, DGP Atul Verma, before retiring, issued an order awarding DGP Disc to 172 police personnel, but it was soon withdrawn by Tiwari. The order issued by Verma read, 'On the recommendations of the committee constituted for the award of DGP Disc-2024, 172 police officers/ officials were awarded with the DGP Disc in recognition of their outstanding work during year 2024.' DGP (jail) SR Ojha also retired on Saturday. The chief secretary issued an order for handing over the additional charge of the jail department to ADGP (law and order) Abhishek Trivedi.

Kardium Announces 1-Year PULSAR IDE Study Results for Its PFA Device – the Globe® PF System
Kardium Announces 1-Year PULSAR IDE Study Results for Its PFA Device – the Globe® PF System

Ottawa Citizen

time25-04-2025

  • Health
  • Ottawa Citizen

Kardium Announces 1-Year PULSAR IDE Study Results for Its PFA Device – the Globe® PF System

Article content VANCOUVER, British Columbia — Kardium Inc., a private medical device company that's advancing the way the world treats atrial fibrillation (AF), announced late-breaking, one-year clinical trial results for its innovative pulsed field ablation (PFA) device—the Globe PF System. These pivotal findings from the PULSAR IDE study were announced at the Heart Rhythm Society (HRS) meeting in San Diego 1, highlighting the safety and efficacy data of the Globe PF System, which is currently under PMA review with the US FDA. Article content Article content Article content Key results included: Article content 'These impressive one‑year efficacy results underscore the advanced catheter design of the Globe PF System,' said Dr. Vivek Reddy, Co-Principal Investigator from The Mount Sinai Fuster Heart Hospital, New York. 'Given the excellent durability achieved by the Globe PF System, the efficacy result is likely approaching the limit of what we can achieve with PV isolation alone.' Article content With just 1.2 applications per vein, the Globe PF System is the true single-shot PFA solution with integrated mapping and ablation built into a single catheter. Article content 'We are very pleased with the study's safety results,' says Dr. Atul Verma, Co-Principal Investigator from McGill University Health Centre in Montreal. 'The Globe PF System has demonstrated an exceptional safety profile and offers many key safety differentiators. Its unique design provides single-shot energy application with precise ablation control that allows us to make individualized patient‑centered treatment decisions.' Article content The PULSAR IDE study is a global, prospective, multicenter, single-arm study to demonstrate the safety and long-term efficacy of the Globe PF System. The study enrolled 183 patients across 12 centers in the United States, Europe, and Canada with symptomatic paroxysmal atrial fibrillation. The data presented at HRS was preliminary and the full data will be included in a publication. Article content 'These are truly outstanding results from the PULSAR IDE study,' said Kevin Chaplin, CEO of Kardium. 'The Globe PF System achieved incredible results for safety, efficacy, durability, PFA applications and procedure times. This study is another big step towards achieving our mission at Kardium of delivering the best treatment for atrial fibrillation.' Article content Atrial fibrillation is the most common type of cardiac arrhythmia and affects more than 8 million people in the United States and nearly 50 million people worldwide. 2 Unlike other catheter ablation systems, the Globe PF System is the only solution of its kind to combine single-shot PV isolation, advanced mapping and atrial ablation into a single catheter. Article content About Kardium Article content We are a rapidly growing, privately held medical solutions company made up of a team of scientists, engineers, creatives and business professionals. Our mission is to deliver the best treatment for atrial fibrillation. Article content Article content CAUTION – Investigational device. Limited by Federal (or United States) law to investigational use. This press release may contain forward-looking statements, which reflect current expectations regarding future events. These forward-looking statements involve risks and uncertainties that may cause actual results, performance or achievements to be materially different from those expressed or implied by such statements. Article content Article content Article content Article content Article content

Kardium Announces 1-Year PULSAR IDE Study Results for Its PFA Device – the Globe® PF System
Kardium Announces 1-Year PULSAR IDE Study Results for Its PFA Device – the Globe® PF System

National Post

time25-04-2025

  • Health
  • National Post

Kardium Announces 1-Year PULSAR IDE Study Results for Its PFA Device – the Globe® PF System

Article content VANCOUVER, British Columbia — Kardium Inc., a private medical device company that's advancing the way the world treats atrial fibrillation (AF), announced late-breaking, one-year clinical trial results for its innovative pulsed field ablation (PFA) device—the Globe PF System. These pivotal findings from the PULSAR IDE study were announced at the Heart Rhythm Society (HRS) meeting in San Diego 1, highlighting the safety and efficacy data of the Globe PF System, which is currently under PMA review with the US FDA. Article content Article content Key results included: Article content 'These impressive one‑year efficacy results underscore the advanced catheter design of the Globe PF System,' said Dr. Vivek Reddy, Co-Principal Investigator from The Mount Sinai Fuster Heart Hospital, New York. 'Given the excellent durability achieved by the Globe PF System, the efficacy result is likely approaching the limit of what we can achieve with PV isolation alone.' Article content With just 1.2 applications per vein, the Globe PF System is the true single-shot PFA solution with integrated mapping and ablation built into a single catheter. Article content 'We are very pleased with the study's safety results,' says Dr. Atul Verma, Co-Principal Investigator from McGill University Health Centre in Montreal. 'The Globe PF System has demonstrated an exceptional safety profile and offers many key safety differentiators. Its unique design provides single-shot energy application with precise ablation control that allows us to make individualized patient‑centered treatment decisions.' Article content The PULSAR IDE study is a global, prospective, multicenter, single-arm study to demonstrate the safety and long-term efficacy of the Globe PF System. The study enrolled 183 patients across 12 centers in the United States, Europe, and Canada with symptomatic paroxysmal atrial fibrillation. The data presented at HRS was preliminary and the full data will be included in a publication. 'These are truly outstanding results from the PULSAR IDE study,' said Kevin Chaplin, CEO of Kardium. 'The Globe PF System achieved incredible results for safety, efficacy, durability, PFA applications and procedure times. This study is another big step towards achieving our mission at Kardium of delivering the best treatment for atrial fibrillation.' Article content Atrial fibrillation is the most common type of cardiac arrhythmia and affects more than 8 million people in the United States and nearly 50 million people worldwide. 2 Unlike other catheter ablation systems, the Globe PF System is the only solution of its kind to combine single-shot PV isolation, advanced mapping and atrial ablation into a single catheter. Article content About Kardium Article content We are a rapidly growing, privately held medical solutions company made up of a team of scientists, engineers, creatives and business professionals. Our mission is to deliver the best treatment for atrial fibrillation. Article content Article content CAUTION – Investigational device. Limited by Federal (or United States) law to investigational use. This press release may contain forward-looking statements, which reflect current expectations regarding future events. These forward-looking statements involve risks and uncertainties that may cause actual results, performance or achievements to be materially different from those expressed or implied by such statements. Article content Article content Article content Article content Article content

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store